Australia TGA ARTG recordTriClip Steerable Guide Catheter - Catheter, intravascular, guiding
Australia TGA ARTG Registered Device · Abbott Vascular Division of Abbott Medical Australia Pty Ltd · Abbott Medical · Class III · Started March 20, 2024
Good Name: Abbott Vascular Division of Abbott Medical Australia Pty Ltd - TriClip Steerable Guide Catheter - Catheter, intravascular, guiding
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- March 20, 2024
- Effective Date
- March 20, 2024
- Name
- Abbott Medical
- Country
- United States of America
- Address
- 177 County Road B East, St Paul, Minnesota, 55117
The TriClip™ G4 System is intended for reconstruction of the insufficient tricuspid valve through tissue approximation. The TriClip device is indicated for patients with severe tricuspid regurgitation who are symptomatic despite medical therapy with valve anatomies that are conducive for transcatheter repair and who have been determined to be at high or greater estimated risk for tricuspid valve surgery by a Heart Team
Access comprehensive regulatory information for TriClip Steerable Guide Catheter - Catheter, intravascular, guiding in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Abbott Vascular Division of Abbott Medical Australia Pty Ltd, manufactured by Abbott Medical in United States of America. The device registration started on March 20, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.